ELISA screening refers to using the Enzyme-Linked Immunosorbent Assay (ELISA) as a high-throughput method to screen a large number of samples for the presence of a specific antigen or antibody.

KMD Bioscience has a well-established yeast three hybrid system and a protein interaction verification platform based on yeast hybrid system.

As of the last update in August 2024, bispecific antibodies have become an exciting and evolving area in immunotherapy, particularly in cancer treatment.

KMD Bioscience can also provide a series of bispecific antibody production, bispecific antibody purification, antibody sequencing and other services

KMD Bioscience can provide antibody production, including recombinant antibody production, polyclonal antibody production, monoclonal antibody production, and antibody fragments production.

Antibody drug conjugate (ADC) technology combines the specificity of monoclonal antibodies with the potent cytotoxic effects of small molecule drugs. KMD Bioscience can provide ADC development service.

KMD Bioscience's scientists are experts working for years in antibody production and thanks to their experience and expertise, a mature antibody production platform with advanced antibody engineering technology has been built.

KMD Bioscience can provide antibody humanization service

Collaborating with KMD Bioscience to produce high-quality humanized antibodies, providing flexible solutions for your next antibody discovery project, KMD Bioscience can provide antibody humanization service.

Cell immortalization refers to the ability of a cell to bypass normal cellular mechanisms that limit its lifespan, allowing it to continuously divide and proliferate beyond the typical limits imposed on regular somatic cells.

Cell immortalization refers to the process of bestowing cells with the ability to proliferate indefinitely. In normal cells, there is a limit to the number of times they can divide due to a phenomenon called cellular senescence.

Cell immortalization, a transformative process that allows cells to evade the natural limits of cellular senescence, has emerged as a cornerstone in biotechnological advancements.

KMD Bioscience can provide small molecule antigen & antibody development services to our customers.

KMD Bioscience is a CRO company providing various biotechnology services, and has established several platforms, such as phage display platform, molecular biology platform, cell biology platform.